×
Site Menu
Everything
Politics
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Health
Sanofi Multiple Sclerosis Drug Gets EU Approval
3 weeks ago
34
The authorization of Cenrifki for the attraction of secondary progressive aggregate sclerosis without relapses follows a rejection from U.S. cause regulators.
Read Entire Article
Homepage
Health
Sanofi Multiple Sclerosis Drug Gets EU Approval
Related
Study shows blood test can help identify people at high risk...
3 hours ago
0
New diagnoses slow in NYC Legionnaires' disease outbreak; so...
5 hours ago
0
Michigan state health officials are narrowing in on lettuce ...
5 hours ago
0
Popular
Archaeology: 18 ancient tombs in Egypt yield 'golden tongue'...
6 days ago
24
Justin Bieber joins Madonna, Shakira and BTS for FIFA World ...
6 days ago
21
Police detain 2 teens after a joy ride in a Waymo in Norther...
6 days ago
20
Why ‘Heated Rivalry’ Received No Emmy Nominations While Conn...
6 days ago
18
Which Country Has the Best-Dressed World Cup Fans?
6 days ago
18